Lexaria Bioscience (LEXX) Cash Flow: Operating & Free Cash Flow

Lexaria Bioscience Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Lexaria Bioscience Corp. (LEXX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Aug 2025	Aug 2024	Aug 2023	Aug 2022	Aug 2021	Aug 2020	Aug 2019	Aug 2018	Aug 2017
Operating Activities
Net Income	-11.91	-5.81	-6.71	-7.38	-4.19	-4.08	-4.16	-6.61	-1.93
Depreciation & Amortization	0.09	0.08	0.15	0.10	0.15	0.15	0.06	0.00	0.00
Stock Based Compensation	0.86	0.49	0.17	1.95	0.41	1.14	0.63	2.60	0.11
Change in Working Capital	0.20	0.11	0.14	-0.35	0.06	-0.19	0.08	-0.37	-0.30
Change in Accounts Receivable	-0.21	-0.04	0.03	-0.14	0.19	-0.09	-0.14	-0.25	-0.01
Change in Inventory	0.00	0.00	0.04	0.00	0.10	0.00	-0.05	-0.03	0.00
Change in Accounts Payable	0.40	0.83	0.09	0.05	0.01	-0.05	0.10	0.00	-0.04
Change in Other Working Capital	0.02	-0.69	-0.01	-0.26	-0.23	-0.06	0.17	-0.10	-0.25
Other Operating Activities	0.32	0.17	0.37	0.80	-0.42	0.37	0.39	1.86	0.57
Net Cash from Operating Activities	-10.45	-4.96	-5.88	-4.88	-3.99	-2.62	-3.01	-2.52	-1.55
Investing Activities
Capital Expenditures	-0.02	-0.04	-0.03	-0.05	-0.08	-0.03	-0.77	-0.09	-0.01
Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.07	0.00
Purchases of Investments	-0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sales/Maturities of Investments	-0.08	-0.15	-0.14	-0.13	0.00	0.01	0.00	0.00	0.00
Other Investing Activities	-0.22	-0.15	-0.14	-0.13	0.27	0.00	-0.12	0.00	0.00
Net Cash from Investing Activities	-0.24	-0.19	-0.17	-0.18	0.19	-0.03	-0.77	-0.16	-0.01
Financing Activities
Debt Repayment	0.00	0.00	0.00	-0.04	-0.07	-0.01	0.00	0.00	-0.05
Common Stock Issued	6.05	10.32	1.59	0.00	9.47	2.67	2.33	1.87	4.05
Other Financing Activities	0.00	6.11	0.00	-0.04	4.02	0.00	1.00	0.00	0.00
Net Cash from Financing Activities	6.05	10.32	1.59	-0.04	13.42	2.65	3.33	1.87	4.00
Summary
Effect of Forex Changes on Cash	-0.05	-0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	-4.70	5.15	-4.46	-5.10	9.62	0.01	-0.44	-0.81	2.44
Cash at Beginning of Period	6.50	1.35	5.81	10.92	1.29	1.29	1.73	2.53	0.09
Cash at End of Period	1.80	6.50	1.35	5.81	10.92	1.29	1.29	1.73	2.53
Free Cash Flow	-10.48	-5.00	-5.91	-4.93	-4.07	-2.65	-3.77	-2.60	-1.56
Supplemental Disclosures
Income Taxes Paid	-	-	0.01	0.00	-0.02	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of May 31, 2026. Data sources and methodology

Frequently Asked Questions About Lexaria Bioscience Cash Flow

What is Lexaria Bioscience's free cash flow?

Lexaria Bioscience had negative free cash flow of $10.48M in fiscal 2025 (fiscal year ended Aug 31, 2025), operating cash flow of −$10.45M minus $24.65K of capital expenditures.

How much does Lexaria Bioscience spend on capital expenditures?

Lexaria Bioscience spent $24.65K on capital expenditures in fiscal 2025, compared with $43.01K a year earlier.

Does Lexaria Bioscience pay dividends or buy back shares?

Lexaria Bioscience's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition